LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021

b'LENSAR, Inc. (NASDAQ: LNSR) (\xe2\x80\x9cLENSAR\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company\xe2\x80\x99s first quarter 2021 financial results will be released before market open on Wednesday, May 5, 2021.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, April 28, 2021
Information
Tags: 
Optical, Health, Surgery, Medical devices, Vision, Light, Senses, Blindness, Cataract, Eye, Ophthalmology
Geotags: 
Florida, United States
⚠ generated by AI ↴
Organisation: 
LENSAR
Summary
Key Points: 
  • b'LENSAR, Inc. (NASDAQ: LNSR) (\xe2\x80\x9cLENSAR\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company\xe2\x80\x99s first quarter 2021 financial results will be released before market open on Wednesday, May 5, 2021.
  • LENSAR\xe2\x80\x99s management will host a conference call and webcast at 8:30 am ET on Wednesday, May 5, 2021 to discuss the financial results and recent corporate highlights.\nTo participate by telephone, please dial (844) 200-6205 (Domestic) or (646) 904-5544 (International).
  • The conference ID number is 760694.
  • To access the live webcast, please go to the Investors section of LENSAR\xe2\x80\x99s website at www.lensar.com .


LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2021 financial results will be released before market open on Wednesday, May 5, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, May 5, 2021 to discuss the financial results and recent corporate highlights.

To participate by telephone, please dial (844) 200-6205 (Domestic) or (646) 904-5544 (International). The conference ID number is 760694. To access the live webcast, please go to the Investors section of LENSAR’s website at www.lensar.com. Following the live webcast, an archived version of the call will be available on the website.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Copyright: 
Copyright Business Wire 2021